Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesClinical/Medical PolicyWPS Health OATS Mosaicplasty Coverage | OpenPayer
    Ask Trek AI about this page
    CurrentWPS Health InsurancePolicy PUM 250-0033-1812

    Cartilage Transfer Procedures: Osteoarticular Transfer System (OATS) and Mosaicplasty Medical Guideline

    Customize your policy alerts

    Sign up for WPS Health Insurance Policy PUM 250-0033-1812 alerts

    Get alerted when Policy PUM 250-0033-1812 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This guideline governs medical necessity and coverage considerations for OATS and mosaicplasty procedures, primarily for focal knee cartilage defects, subject to plan-specific terms, exclusions, authorization requirements, and applicable law.

    Policy Summary
    PayerWPS Health Insurance
    PolicyCartilage Transfer Procedures: OATS and Mosaicplasty
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateOctober 1, 2026
    Last ReviewSep 10, 2026
    Next Review DateN/A
    Key ActionSubmit a Standard Written Order, relevant medical records, documentation of medical necessity, and correct coding for the requested service.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    15-55Age range
    35Maximum BMI
    2 monthsMedication trial
    Grade III-IVDefect severity

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    10
    Experimental procedure uses
    15Additional unproven treatments

    Medical Necessity and Coverage Determinations

    Medically necessary knee OATS or mosaicplasty

    OATS, whether autograft or allograft, or mosaicplasty of the knee is medically necessary when ALL of the following are met:

    All medical necessity criteria

    • Patient age and skeletal maturity: The individual is between 15 and 55 years old. For individuals younger than 18 years, closure of the growth plate must be documented.Age 15–55 years; growth plate closure documented if younger than 18
    • Cartilage defect: There is a focal, full-thickness articular cartilage defect, Grade III or IV, caused by acute or repetitive trauma.Grade III or IV
    • Functional symptoms: Knee dysfunction or pain affects the individual's ability to ambulate or complete activities of daily living.
    • Medication management: The individual has completed a two-month trial of medication management.2 months
    • Knee replacement candidacy: The individual is not an appropriate candidate for total knee replacement.
    • Surrounding cartilage and osteoarthritis: Surrounding articular cartilage has absent or minimal degenerative changes, Outerbridge Grade II or less, with only mild, if any, significant osteoarthritic changes elsewhere in the knee, as shown by MRI and/or radiographs.Outerbridge Grade II or less
    • Defect border: Normal-appearing hyaline cartilage surrounds the border of the defect.
    • Alignment and stability: The knee is aligned and stable with normal weight distribution within the joint, or a procedure to ensure alignment, stability, and normal weight distribution is planned in combination with or before OATS or mosaicplasty.
    • Body mass index: The individual's BMI is less than or equal to 35.BMI ≤35

    Uses outside or failing the coverage criteria

    The following coverage logic applies to uses outside or within the listed indications.

    Not medically necessary or unproven use

    • Unlisted indication: The procedure is used for a condition or diagnosis other than one listed in the indications of coverage.

      Considered experimental, investigational, and unproven to affect health outcomes.

    • Listed indication without meeting criteria: The condition or diagnosis is listed in the indications of coverage, but the medical necessity criteria are not met.

      Considered not medically necessary.

    Experimental, investigational, and unproven services

    The following procedures, conditions, products, and treatments are considered experimental, investigational, and unproven to affect health outcomes.

    • Combined or hybrid procedures: Combined or hybrid OATS or mosaicplasty with autologous chondrocyte implantation (ACI or MACI), or with adipose-derived stem cell therapy.
    • Nonstandard graft or transplant techniques and products: Non-autologous mosaicplasty using resorbable synthetic bone filler; autologous cartilage chip transplantation; minced cartilage or biopaste extracellular matrix products, whether synthetic, autograft, or allograft; synthetic resorbable polymers or synthetic grafts; juvenile cartilage allograft tissue implantation; or cryopreserved viable osteochondral allograft products.
    • Anatomic or age exclusions: OATS or mosaicplasty is performed on any joint other than the knee; for an individual younger than 15 or older than 55; or involving proximal tibial cartilage.

    The following uses of OATS or mosaicplasty are considered experimental, investigational, and unproven to affect health outcomes: combined or hybrid procedures with ACI, MACI, or adipose-derived stem cell therapy; non-autologous mosaicplasty using resorbable synthetic bone filler; autologous cartilage chip transplantation; minced cartilage or biopaste extracellular matrix products; synthetic resorbable polymers or synthetic grafts; juvenile cartilage allograft tissue implantation; and cryopreserved viable osteochondral allograft products.

    This classification also applies to procedures performed on any joint other than the knee, for individuals younger than 15 or older than 55, or involving proximal tibial cartilage. OATS or mosaicplasty performed with an uncorrected congenital blood coagulation disorder or malignancy at the cartilage harvest or defect site is likewise considered experimental, investigational, and unproven.

    Subchondroplasty or subchondral calcium phosphate injections; platelet-rich plasma; stem cell therapy; bone marrow aspirate concentrate; microfragmented adipose tissue; platelet lysate; viscosupplementation or hyaluronic acid injections; peripheral nerve block or ablation; genicular nerve injections or radiofrequency ablation; the iovera System; Coolief Cooled RF; and cryotherapy are also considered experimental, investigational, and unproven when used in this context.

    When the condition or diagnosis is listed in the indications of coverage but the applicable medical-necessity criteria are not met, the procedure is considered not medically necessary. A procedure used for a condition or diagnosis that is not listed in the indications of coverage is considered experimental, investigational, and unproven to affect health outcomes.

    Documentation and Determination Requirements

    Documentation Required

    Required Documentation

    Submit the required clinical and billing documentation to support the requested OATS or mosaicplasty service and medical necessity.

    • Standard Written Order (SWO) prescribed by a qualified healthcare provider and documenting the member’s diagnosis.
    • Medical record information, including office visit notes, continued need/use when applicable, and supporting documentation of medical necessity.
    • Correct coding for the item or service that meets all applicable coding guidelines.
    Documentation Required

    Growth Plate Documentation Required

    For individuals younger than 18 years, document closure of the growth plate before OATS or mosaicplasty is considered medically necessary.

    • The individual must be between 15 and 55 years of age.
    • Growth plate closure documentation is required for individuals younger than 18 years.

    Cartilage Transfer Procedure Overview

    Cartilage transfer procedures move healthy cartilage from a normal, non-weight-bearing area of the knee to an area of damaged cartilage. Mosaicplasty transfers multiple small plugs of healthy hyaline cartilage, while OATS generally transfers one or two larger osteochondral plugs. The graft may be an autograft from the same individual or an allograft from a cadaveric donor; autografts are typically used for smaller lesions and allografts for larger defects.

    Key Procedure and Graft Terms

    Mosaicplasty
    ProcedureTransfers healthy cartilage to an area of damaged cartilage.
    Graft materialMultiple small plugs of healthy hyaline cartilage.
    ResultProduces a mosaic-tile appearance in the treated area.
    Osteoarticular Transfer System (OATS)
    ProcedureTransfers healthy cartilage to a cartilage defect.
    Graft materialOne or two larger healthy hyaline cartilage plugs.
    Alternative nameOsteoarticular Transfer System (OATS).
    Policy Summary
    PayerWPS Health Insurance
    PolicyCartilage Transfer Procedures: OATS and Mosaicplasty
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateOctober 1, 2026
    Last ReviewSep 10, 2026
    Next Review DateN/A
    Key ActionSubmit a Standard Written Order, relevant medical records, documentation of medical necessity, and correct coding for the requested service.
    SourceLink
    On This Page
    Medical Necessity and Coverage DeterminationsDocumentation and Determination RequirementsCartilage Transfer Procedure OverviewKey Procedure and Graft Terms
    Medical conditions:
    OATS or mosaicplasty is performed for an individual with an uncorrected congenital blood coagulation disorder or in the presence of malignancy in the area of cartilage harvest or defect.
  1. Additional injections, therapies, nerve procedures, or cryotherapy: Subchondroplasty or subchondral calcium phosphate injections; platelet-rich plasma (PRP) injection or treatment; stem cell therapy, injection, or transplant; bone marrow aspirate concentrate (BMAC) injection or treatment; microfragmented adipose tissue (MFAT) injection or treatment; platelet lysate; viscosupplementation or hyaluronic acid injections; peripheral nerve block or ablation; genicular nerve injections or genicular nerve radiofrequency ablation; iovera System; Coolief Cooled RF; or cryotherapy.
  2. Denial Risk

    Unlisted Diagnosis or Condition

    When OATS or mosaicplasty is used for a condition or diagnosis other than one listed in the indications of coverage, the use is considered experimental, investigational, and unproven to affect health outcomes.

    • Review the diagnosis against the policy’s listed indication: a focal full-thickness articular cartilage defect of the knee caused by acute or repetitive trauma.
    • An unlisted diagnosis or condition is not covered as medically necessary under this guideline.
    Denial Risk

    Criteria Not Met

    When the condition or diagnosis is listed in the indications of coverage but one or more required criteria are not met, the service is considered not medically necessary.

    • All applicable coverage criteria must be satisfied, including age, defect characteristics, functional symptoms, medication-management trial, suitability for knee replacement, surrounding cartilage and joint condition, cartilage border, knee alignment and stability, and BMI of 35 or less.
    • Failure to meet any required criterion results in a not medically necessary determination.
    Denial Risk

    Experimental or Unproven Uses

    The following procedures, products, combinations, and uses are considered experimental, investigational, and unproven to affect health outcomes.

    • Combined or hybrid OATS or mosaicplasty with autologous chondrocyte implantation (ACI or MACI) or adipose-derived stem cell therapy.
    • Non-autologous mosaicplasty using resorbable synthetic bone filler; autologous cartilage chip transplantation; subchondroplasty or subchondral calcium phosphate injections; and OATS or mosaicplasty of the proximal tibial cartilage.
    • OATS or mosaicplasty on any joint other than the knee, or for an individual younger than 15 or older than 55 years.
    • Minced cartilage or biopaste extracellular matrix products, including BioCartilage®; synthetic resorbable polymers or synthetic grafts, including TruFit®, TruGraft®, and PolyGraft® PGS; and juvenile cartilage allograft tissue implantation, including DeNovo NT® and DeNovo ET®.
    • Platelet-rich plasma (PRP), stem cell therapy, injection, or transplant; bone marrow aspirate concentrate (BMAC); microfragmented adipose tissue (MFAT), including Lipogems®; and platelet lysate (PL).
    • Viscosupplementation or hyaluronic acid injections, including Orthovisc® and Synvisc®; peripheral nerve block or ablation; genicular nerve injections or genicular nerve radiofrequency ablation; iovera® System; Coolief® Cooled RF; and cryotherapy.
    • Cryopreserved viable osteochondral allograft products, including Cartiform®.
    Denial Risk

    Contraindicating Conditions

    OATS or mosaicplasty is considered experimental, investigational, and unproven when performed in the presence of specified contraindicating conditions.

    • Uncorrected congenital blood coagulation disorder.
    • Malignancy in the area of cartilage harvest or the cartilage defect.
    Autograft
    DefinitionA graft in which the bone and cartilage plug is taken from the same individual.
    Typical sourceThe less weight-bearing portion of the femur.
    Typical useTypically used for smaller lesions.
    Allograft
    DefinitionA graft in which the cartilage and bone are taken from a cadaveric donor.
    Donor sourceCadaveric donor tissue provides the cartilage and bone.
    Typical useTypically used for larger defects.